{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:23:18Z","timestamp":1765545798813},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mutation Research\/Genetic Toxicology and Environmental Mutagenesis"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.mrgentox.2012.10.009","type":"journal-article","created":{"date-parts":[[2012,11,8]],"date-time":"2012-11-08T09:52:50Z","timestamp":1352368370000},"page":"19-26","source":"Crossref","is-referenced-by-count":10,"title":["Pretreatment with valproic acid, a histone deacetylase inhibitor, enhances the sensitivity of the peripheral blood micronucleus assay in rodents"],"prefix":"10.1016","volume":"751","author":[{"given":"T.","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Shekh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vikram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.V.","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.B.","family":"Jena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrgentox.2012.10.009_bib0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/mutage\/10.4.297","article-title":"Genotoxicity testing: current practices and strategies used by the pharmaceutical industry","volume":"10","author":"Purves","year":"1995","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0010","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/toxsci\/kfm019","article-title":"Genetic toxicity assessment: employing the best science for human safety evaluation part IV: recommendation of a working group of the Gesellschaft fuer Umwelt-Mutationsforschung (GUM) for a simple and straightforward approach to genotoxicity testing","volume":"97","author":"Pfuhler","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/mutage\/gep060","article-title":"Combining the in vivo comet and micronucleus assays: a practical approach to genotoxicity testing and data interpretation","volume":"25","author":"Vasquez","year":"2010","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0020","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ijheh.2005.05.002","article-title":"Polymorphisms of DNA repair gene XPD and DNA damage of workers exposed to vinylchloride monomer","volume":"208","author":"Zhu","year":"2005","journal-title":"Int. J. Hyg. Environ. Health"},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/1098-2280(2000)36:3<163::AID-EM1>3.0.CO;2-P","article-title":"Micronucleated erythrocyte frequency in peripheral blood of B6C3F(1) mice from short-term, prechronic, and chronic studies of the NTP carcinogenesis bioassay program","volume":"36","author":"Witt","year":"2000","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/mutage\/10.1.31","article-title":"Combination effects of clastogens in the mouse peripheral blood micronucleus assay","volume":"10","author":"Suzuki","year":"1995","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0035","first-page":"418","article-title":"Evaluation of the micronucleus test in peripheral blood erythrocytes by use of the splenectomized model","volume":"49","author":"Ramirez-Munoz","year":"1999","journal-title":"Lab. Anim. Sci."},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0040","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0027-5107(84)90018-6","article-title":"The persistence of micronucleated erythrocytes in the peripheral circulation of normal and splenectomized Fischer 344 rats: implications for cytogenetic screening","volume":"127","author":"Schlegel","year":"1984","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/mutage\/gem015","article-title":"Prior bleeding enhances the sensitivity of peripheral blood and bone marrow micronucleus tests in rats","volume":"22","author":"Vikram","year":"2007","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0050","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0165-1218(96)90072-5","article-title":"Induction of micronuclei by low doses of azidothymidine (AZT)","volume":"368","author":"Dertinger","year":"1996","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/em.20081","article-title":"Interlaboratory validation of a CD71-based flow cytometric method (Microflow) for the scoring of micronucleated reticulocytes in mouse peripheral blood","volume":"45","author":"Torous","year":"2005","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0060","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/toxsci\/kfg143","article-title":"Comparative scoring of micronucleated reticulocytes in rat peripheral blood by flow cytometry and microscopy","volume":"74","author":"Torous","year":"2003","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mrgentox.2007.08.004","article-title":"Comparison of flow cytometry- and microscopy-based methods for measuring micronucleated reticulocyte frequencies in rodents treated with nongenotoxic and genotoxic chemicals","volume":"649","author":"Witt","year":"2008","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.yrtph.2008.07.005","article-title":"Pre-bled-young-rats in genotoxicity testing: a model for peripheral blood micronucleus assay","volume":"52","author":"Vikram","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0075","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/mutage\/geq099","article-title":"Simultaneous use of erythropoietin and prior bleeding enhances the sensitivity of the peripheral blood micronucleus assay","volume":"26","author":"Mughal","year":"2011","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0080","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2165\/00003495-199447020-00008","article-title":"Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy","volume":"47","author":"Davis","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jad.2006.04.030","article-title":"Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature","volume":"95","author":"Nasrallah","year":"2006","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0090","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0095","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.reprotox.2011.09.007","article-title":"Investigation on sodium valproate induced germ cell damage, oxidative stress and genotoxicity in male Swiss mice","volume":"32","author":"Khan","year":"2011","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0100","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1158\/1535-7163.MCT-05-0194","article-title":"In vivo synergy between topoisomerase II and histone deacetylase inhibitors: predictive correlates","volume":"4","author":"Marchion","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0105","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ctrv.2007.11.003","article-title":"Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors","volume":"34","author":"Duenas-Gonzalez","year":"2008","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.canlet.2008.03.037","article-title":"Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy","volume":"269","author":"Carew","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0115","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1158\/0008-5472.CAN-04-2478","article-title":"Valproic acid alters chromatin structure by regulation of chromatin modulation proteins","volume":"65","author":"Marchion","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s002800000111","article-title":"Maximum tolerated doses of methotrexate and 7-hydroxy-methotrexate in a model of acute toxicity in rats","volume":"46","author":"Fuskevag","year":"2000","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0125","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1464-410X.2009.08795.x","article-title":"Inhibition of bladder tumour growth by histone deacetylase inhibitor","volume":"105","author":"Ozawa","year":"2010","journal-title":"BJU Int."},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mrgentox.2006.08.010","article-title":"In vivo erythrocyte micronucleus assay III. Validation and regulatory acceptance of automated scoring and the use of rat peripheral blood reticulocytes, with discussion of non-hematopoietic target cells and a single dose-level limit test","volume":"627","author":"Hayashi","year":"2007","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1383-5742(99)00053-8","article-title":"The HUman MicroNucleus Project\u2014an international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans","volume":"428","author":"Fenech","year":"1999","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/toxsci\/kfm177","article-title":"The dynamic epigenome and its implications in toxicology","volume":"100","author":"Szyf","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0145","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1158\/1078-0432.CCR-08-1930","article-title":"Clinical and biological effects of valproic acid as a histone deacetylase inhibitor on tumor and surrogate tissues: phase I\/II trial of valproic acid and epirubicin\/FEC","volume":"15","author":"Munster","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0150","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1371\/journal.pone.0000098","article-title":"A proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer","volume":"1","author":"Arce","year":"2006","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/sj.bjc.6604817","article-title":"A phase I\u2013II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma","volume":"100","author":"Rocca","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0160","first-page":"7291","article-title":"Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA","volume":"63","author":"Kim","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrgentox.2012.10.009_bib0165","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/03602530600688503","article-title":"CYP4B1: an enigmatic P450 at the interface between xenobiotic and endobiotic metabolism","volume":"38","author":"Baer","year":"2006","journal-title":"Drug Metab. Rev."}],"container-title":["Mutation Research\/Genetic Toxicology and Environmental Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383571812003415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383571812003415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T15:54:26Z","timestamp":1540137266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383571812003415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1383571812003415"],"URL":"https:\/\/doi.org\/10.1016\/j.mrgentox.2012.10.009","relation":{},"ISSN":["1383-5718"],"issn-type":[{"value":"1383-5718","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}